Advertisement
Canada markets closed
  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CAD/USD

    0.7275
    +0.0012 (+0.16%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • Bitcoin CAD

    88,304.96
    +908.98 (+1.04%)
     
  • CMC Crypto 200

    1,385.63
    +73.00 (+5.56%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     
  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     
  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     
  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

New Strong Buy Stocks for May 8th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Acacia Communications, Inc. (ACIA): This company that develops, manufactures, and sells high-speed coherent optical interconnect products has seen the Zacks Consensus Estimate for its current year earnings increasing 18.7% over the last 60 days.

Acacia Communications Inc Price and Consensus

 

Acacia Communications Inc Price and Consensus
Acacia Communications Inc Price and Consensus

Acacia Communications Inc price-consensus-chart | Acacia Communications Inc Quote

NeuBase Therapeutics, Inc. (NBSE): This pre-clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 32.1% over the last 60 days.

ADVERTISEMENT

NeuBase Pharmaceuticals Inc Price and Consensus

 

Ohr Pharmaceuticals Inc Price and Consensus
Ohr Pharmaceuticals Inc Price and Consensus

NeuBase Pharmaceuticals Inc price-consensus-chart | NeuBase Pharmaceuticals Inc Quote

Chegg, Inc. (CHGG): This company that operates direct-to-student learning platform has seen the Zacks Consensus Estimate for its current year earnings increasing 12% over the last 60 days.

Chegg Inc Price and Consensus

 

Chegg Inc Price and Consensus
Chegg Inc Price and Consensus

Chegg Inc price-consensus-chart | Chegg Inc Quote

Gossamer Bio, Inc. (GOSS): This clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 2.1% over the last 60 days.

Gossamer Bio Inc Price and Consensus

 

Gossamer Bio Inc Price and Consensus
Gossamer Bio Inc Price and Consensus

Gossamer Bio Inc price-consensus-chart | Gossamer Bio Inc Quote

Minerva Neurosciences, Inc. (NERV): This company that focuses on the development and commercialization of a portfolio of product candidates for the treatment of central nervous system diseases has seen the Zacks Consensus Estimate for its current year earnings increasing 9% over the last 60 days.

Minerva Neurosciences Inc Price and Consensus

 

Minerva Neurosciences Inc Price and Consensus
Minerva Neurosciences Inc Price and Consensus

Minerva Neurosciences Inc price-consensus-chart | Minerva Neurosciences Inc Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Minerva Neurosciences Inc (NERV) : Free Stock Analysis Report
 
Ohr Pharmaceuticals Inc (NBSE) : Free Stock Analysis Report
 
Gossamer Bio Inc (GOSS) : Free Stock Analysis Report
 
Chegg Inc (CHGG) : Free Stock Analysis Report
 
Acacia Communications Inc (ACIA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research